(Q36978156)

17 August 2017

1 reference

title

Immunosuppressive therapy in older cardiac transplant patients (English)

1 reference

17 August 2017

author name string

Arezu Zejnab Aliabadi

series ordinal

1

1 reference

17 August 2017

Andreas Oliver Zuckermann

series ordinal

2

1 reference

17 August 2017

Michael Grimm

series ordinal

3

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

24

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

913-932

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200724110-00004

17 August 2017

exact match

0 references

cites work

24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization

1 reference

12 December 2020

Hepatotoxicity of transplant immunosuppressive agents

1 reference

12 December 2020

Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

1 reference

12 December 2020

Heart transplantation in elderly patients

1 reference

12 December 2020

Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.

1 reference

12 December 2020

Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure

1 reference

12 December 2020

Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients

1 reference

12 December 2020

Clinical relevance of age-related immune dysfunction

1 reference

12 December 2020

Immunosenescence: impact in the young as well as the old?

1 reference

12 December 2020

The use of mycophenolate mofetil in transplant recipients

1 reference

12 December 2020

Drug therapy in the elderly

1 reference

12 December 2020

Treatment of allograft vasculopathy in heart transplantation

1 reference

12 December 2020

Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure

1 reference

12 December 2020

European multicenter tacrolimus heart pilot study: three year follow-up.

1 reference

12 December 2020

Rejection and recipient age.

1 reference

12 December 2020

Long-term results of cardiac transplantation in patients older than sixty years. UTAH Cardiac Transplant Program

1 reference

12 December 2020

Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age.

1 reference

12 December 2020

European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results--European Tacrolimus Multicenter Heart Study Group

1 reference

12 December 2020

An analysis of the effect of age on survival after heart transplant

1 reference

12 December 2020

Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine

1 reference

12 December 2020

A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation.

1 reference

12 December 2020

Cardiac transplantation with corticosteroid-free immunosuppression: Long-term result

1 reference

12 December 2020

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

1 reference

12 December 2020

Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3

1 reference

12 December 2020

Transplantation in the elderly: a review

1 reference

12 December 2020

Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.

1 reference

12 December 2020

Congestive heart failure is associated with the rate of bone loss

1 reference

12 December 2020

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

12 December 2020

Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation

1 reference

12 December 2020

Cyclosporin nephrotoxicity following cardiac transplantation

1 reference

12 December 2020

Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring

1 reference

12 December 2020

Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients

1 reference

12 December 2020

Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation

1 reference

12 December 2020

Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial

1 reference

12 December 2020

Chronic injury of human renal microvessels with low-dose cyclosporine therapy.

1 reference

12 December 2020

Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group

1 reference

12 December 2020

Thirty years of cardiac transplantation at Stanford university

1 reference

12 December 2020

Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation

1 reference

12 December 2020

The impact of diabetes mellitus at the time of heart transplantation on long-term survival

1 reference

12 December 2020

Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome

1 reference

12 December 2020

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines

1 reference

12 December 2020

Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation

1 reference

12 December 2020

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life.

1 reference

12 December 2020

Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center

1 reference

12 December 2020

Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference

1 reference

12 December 2020

The pathologic changes in long-term heart and lung transplant survivors

1 reference

12 December 2020

Progression of steroid-associated osteoporosis after heart transplantation

1 reference

12 December 2020

Cardiac transplantation: the Stanford experience in the cyclosporine era.

1 reference

12 December 2020

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007.

1 reference

12 December 2020

Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation

1 reference

12 December 2020

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

1 reference

12 December 2020

Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine

1 reference

12 December 2020

Daclizumab to prevent rejection after cardiac transplantation

1 reference

12 December 2020

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

1 reference

12 December 2020

Cardiac transplantation in the older recipient: excellent long-term survival based on pretransplant screening

1 reference

12 December 2020

Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.

1 reference

12 December 2020

Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment

1 reference

12 December 2020

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

12 December 2020

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

1 reference

12 December 2020

1 reference

12 December 2020

Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction

1 reference

12 December 2020

Differential characteristics of heart transplantation in patients older than 60 years

1 reference

12 December 2020

Long-term results of tacrolimus monotherapy in cardiac transplant recipients

1 reference

12 December 2020

A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience.

1 reference

12 December 2020

Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection

1 reference

12 December 2020

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

12 December 2020

Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry

1 reference

12 December 2020

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 reference

12 December 2020

1 reference

12 December 2020

Pathogenesis of bone loss in heart transplant candidates and recipients

1 reference

12 December 2020

A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3.

1 reference

12 December 2020

Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model

1 reference

12 December 2020

Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy

1 reference

12 December 2020

Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure

1 reference

12 December 2020

Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age

1 reference

12 December 2020

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

1 reference

12 December 2020

Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group

1 reference

12 December 2020

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy

1 reference

12 December 2020

Cancer after kidney transplantation in the United States

1 reference

12 December 2020

Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation.

1 reference

12 December 2020

In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model

1 reference

12 December 2020

A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation

1 reference

12 December 2020

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

1 reference

12 December 2020

A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation

1 reference

12 December 2020

The role of therapeutic monitoring of everolimus in solid organ transplantation

1 reference

12 December 2020

Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation

1 reference

12 December 2020

Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil

1 reference

12 December 2020

Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients

1 reference

12 December 2020

Aging and the environment: a research framework

1 reference

12 December 2020

Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial

1 reference

12 December 2020

A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients

1 reference

12 December 2020

Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database

1 reference

12 December 2020

The need for a tailored immunosuppression in older heart transplant recipients

1 reference

12 December 2020

Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation

1 reference

12 December 2020

Bisphosphonates routine in prevention of post-transplant osteoporosis?

1 reference

12 December 2020

Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.

1 reference

12 December 2020

Exponentially increased risk of infectious death in older renal transplant recipients

1 reference

12 December 2020

A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study.

1 reference

12 December 2020

Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study

1 reference

12 December 2020

Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression

1 reference

12 December 2020

Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

1 reference

12 December 2020

Bone loss after cardiac transplantation

1 reference

12 December 2020

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

1 reference

12 December 2020

Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity

1 reference

12 December 2020

Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosp

1 reference

12 December 2020

Long-term results of heart transplantation in patients older than 60 years

1 reference

12 December 2020

Sirolimus: the evidence for clinical pharmacokinetic monitoring.

1 reference

12 December 2020

Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients

1 reference

12 December 2020

Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.

1 reference

12 December 2020

Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients

1 reference

12 December 2020

Advantages of C2 Monitoring to Avoid Acute Rejection in Pediatric Heart Transplant Recipients

1 reference

12 December 2020

Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.

1 reference

12 December 2020

Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis

1 reference

12 December 2020

Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial

1 reference

12 December 2020

Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients

1 reference

12 December 2020

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

1 reference

12 December 2020

Immunosuppressive drugs and cancer

1 reference

12 December 2020

Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.

1 reference

12 December 2020

OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients

1 reference

12 December 2020

Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation

1 reference

12 December 2020

A prospective study of renal structure and function in psoriasis patients treated with cyclosporin

1 reference

12 December 2020

Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease

1 reference

12 December 2020

Cyclosporine neurotoxicity.

1 reference

12 December 2020

Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.

1 reference

12 December 2020

Long-term renal function in heart transplant recipients receiving cyclosporine therapy

1 reference

12 December 2020

Predicting the occurrence of diabetes mellitus in recipients of heart transplants

1 reference

12 December 2020

Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients

1 reference

12 December 2020

Sirolimus for Kaposi's sarcoma.

1 reference

12 December 2020

Effects of early steroid withdrawal after heart transplantation

1 reference

12 December 2020

The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection

1 reference

12 December 2020

Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors

1 reference

12 December 2020

Chronic renal failure after transplantation of a nonrenal organ

1 reference

12 December 2020

Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients

1 reference

12 December 2020

Insights into chronic cyclosporine nephrotoxicity.

1 reference

12 December 2020

Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian

1 reference

12 December 2020

Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference

1 reference

12 December 2020

Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failurefn1fn1This work was supported in part by Grants AR-41391 and RR-006645 from the National Institutes of Health

1 reference

12 December 2020

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.

1 reference

12 December 2020

Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?

1 reference

12 December 2020

The spectrum of ciclosporin nephrotoxicity

1 reference

12 December 2020

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction

1 reference

12 December 2020

Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy

1 reference

12 December 2020

Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule

1 reference

12 December 2020

Incidence and prognosis of cancer following heart transplantation using RATG induction therapy

1 reference

12 December 2020

Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity

1 reference

12 December 2020

Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits

1 reference

12 December 2020

Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

Kaposi sarcoma in solid organ transplant recipients: a single center report

1 reference

12 December 2020

Markers of bone metabolism in congestive heart failure

1 reference

12 December 2020

Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?

1 reference

12 December 2020

Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age

1 reference

12 December 2020

Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression

1 reference

12 December 2020

10.2165/00002512-200724110-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1041172053

0 references

1 reference